2004Journal watchRequires access

Safe Use of NRTIs After Symptomatic Hyperlactatemia

Raphael J. Landovitz

Open publisher page 0 citations

Abstract

NRTIs are the backbone of potent antiretroviral regimens, and patients who have complications of NRTI therapy are left with few well-studied treatment options. NRTIs, by virtue of their activity against human DNA-polymerase (gamma), a uniquely mitochondrial enzyme, all have the potential to be mitochondrial poisons. NRTIs often cause benign and asymptomatic elevations in serum lactate. Less frequently, patients develop symptomatic hyperlactatemia or even frank lactic acidosis, which is associated with substantial morbidity and mortality in this population. Few reports exist regarding the introduction of less mitochondrially toxic NRTIs in the wake of symptomatic hyperlactatemia and discontinuation of the offending agents. Researchers reviewed charts of patients seen from July 1998 to September 2002 …

About this research paper

What this paper is about

NRTIs are the backbone of potent antiretroviral regimens, and patients who have complications of NRTI therapy are left with few well-studied treatment options. NRTIs, by virtue of their activity against human DNA-polymerase (gamma), a uniquely mitochondrial enzyme, all have the potential to be mitochondrial poisons. NRTIs often cause benign and asymptomatic elevations in serum lactate. Less frequently, patients develop symptomatic hyperlactatemia or even frank lactic acidosis, which is associated with substantial morbidity and mortality in this population. Few reports exist regarding the introduction of less mitochondrially toxic NRTIs in the wake of symptomatic hyperlactatemia and discontinuation of the offending agents. Researchers reviewed charts of patients seen from July 1998 to September 2002 …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

NRTIs are the backbone of potent antiretroviral regimens, and patients who have complications of NRTI therapy are left with few well-studied treatment options. NRTIs, by virtue of their activity against human DNA-polymerase (gamma), a uniquely mitochondrial enzyme, all have the potential to be mitochondrial poisons. NRTIs often cause benign and asymptomatic elevations in serum lactate. Less frequently, patients develop symptomatic hyperlactatemia or even frank lactic acidosis, which is associated with substantial morbidity and mortality in this population. Few reports exist regarding the introduction of less mitochondrially toxic NRTIs in the wake of symptomatic hyperlactatemia and discontinuation of the offending agents. Researchers reviewed charts of patients seen from July 1998 to September 2002 …

Key concepts: Hyperlactatemia, Medicine, Lactic acidosis, Discontinuation, Asymptomatic, Internal medicine, Population, Environmental health

Related papers

Back to paper searchBrowse research topicsOriginal source
Safe Use of NRTIs After Symptomatic Hyperlactatemia — Research Paper | ScholarLens